• Aerin Medical entered a multi-year strategic partnership with US ENT Partners, the largest otolaryngology group purchasing organization.
• US ENT Partners named Aerin its preferred vendor for radiofrequency technology, recommending VivAer and RhinAer across its network.
• Agreement targets adoption for chronic rhinitis, nasal airway obstruction across more than 1,500 physicians, 300 member practices.
• Partnership expands Aerin’s commercial reach, building on more than 200,000 patients treated with VivAer and RhinAer.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aerin Medical Inc. published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.